abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 1 252 sessions, November 6, 2025 to November 6, 2026
- Largest daily move
- -5.4% close of November 5, 2026
- 1-year change
- +12.6% closing prices, November 6, 2025 to November 6, 2026
- 1-month change
- +3% closing prices, October 6, 2026 to November 6, 2026
Company Description
abrdn Life Sciences Investors (NYSE: HQL) is classified in the asset management industry within the Financial Services sector and carries a market capitalization of $559.8M.
HQL has gained 12.6% over the past year. The last closing price was $18.09.
This page collects what Stock Titan holds for HQL, including price data, latest news, SEC filings, and short interest trends.
Stock Performance
abrdn Life Sciences Investors (HQL) closed at $18.09 on November 6, 2026. Over the past 12 months, the price has gained 12.6%.
HQL Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
abrdn Life Sciences Investors has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include buybacks. View all HQL news →
SEC Filings
abrdn Life Sciences Investors has filed 10 recent SEC filings, including 4 Form SCHEDULE 13D/A, 2 Form 3, 2 Form 4, 2 Form SCHEDULE 13G/A. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all HQL SEC filings →
Short Interest History
Short interest in abrdn Life Sciences Investors (HQL) currently stands at 192.7 thousand shares, up 70.8% from the previous reporting period, representing 0.6% of the shares outstanding. Since November 2025, short interest has increased by 111.7%.
Days to Cover History
Days to cover for abrdn Life Sciences Investors (HQL) currently stands at 1.4 days, up 38% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 38%.
HQL Company Profile & Sector Positioning
abrdn Life Sciences Investors (HQL) operates in the Asset Management industry within the broader Financial Services sector and is listed on the NYSE. Among dividend-paying stocks, HQL ranks #93 by dividend yield.
Investors comparing HQL often look at related companies in the same sector, including Calamos Dynamic Convertible & Income Fund (CCD), MSC Income Fund, Inc. (MSIF), Blackrock Debt Strategies Fund, Inc. (DSU), Vinci Compass Investments Ltd. (VINP), and Cohen & Steers Limited Duration Preferred and Income Fund Inc (LDP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HQL's relative position within its industry.